Cronus Pharma Specialities India Private Limited - Company Profile

It is a chemicals private limited company based in Shaikpet, Telangana, India, established in 2015.
2015 Shaikpet, Telangana, India Active
Last Updated:
Access Report
About Cronus Pharma Specialities India Private Limited

Cronus Pharma Specialities India Private Limited, a active private limited company, was established on 02 September 2015 in Shaikpet, Telangana, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24232TG2015PTC100543. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹190.00 Cr and a paid-up capital of ₹119.11 Cr.

It upholds a compliant status. Employing 272 professional, Its leadership includes Mallemputi Ramakrishna Chowdary (Director), Kavuru Vimal Kumar (Director). Past directors included Satyanarayana Swarna, Bhaskar Rao Vamsi Krishna Velaga, Muralikrishna Prasad Vallabhaneni. It holds ₹297.00 Cr open charges and no settled loans. Its latest AGM occurred on 21 July 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 26/B, 19Th Floor , The Headquarters, Orbit, Plot No 30/C, Sy No 83/1, Hyderabad Knowledge City, Raidurg ,Serilingampally Mandal, Shaikpet, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2015PTC100543

  • Registration Number

    100543

  • Incorporation Date

    02 September 2015

  • Authorized Capital

    ₹190.00 Cr

  • Paid-Up Capital

    ₹119.11 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 190.00 Cr
  • Paid Up Capital ₹ 119.11 Cr
  • Company Age 10 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 297.00 Cr
  • Revenue Growth **** 83.83%
  • Profit Growth **** 153.77%
  • Ebitda **** 183.84%
  • Net Worth 159.38%
  • Total Assets **** 7.86%
Company report

Cronus Pharma Specialities India Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Cronus Pharma Specialities India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cronus Pharma Specialities India Private Limited?
Current Directors
Name Designation Appointment Date Status
Mallemputi Ramakrishna Chowdary Director 02 Sep 2015 Current
Kavuru Vimal Kumar Director 16 Jul 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 26 Sep 2018 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cronus Pharma Specialities India.

Cronus Pharma Specialities India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 83.83% increase. The company also saw a substantial improvement in profitability, with a 153.77% increase in profit. The company's net worth Soared by an impressive increase of 159.38%.

Cronus Pharma Specialities India revenue growth over time
Cronus Pharma Specialities India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 83.83%
*******
*******
*******
*******
Revenue from Operations
*******
 78.04%
*******
*******
*******
*******
Total Assets
*******
 7.86%
*******
*******
*******
*******
Profit or Loss
*******
 153.77%
*******
*******
*******
*******
Net Worth
*******
 159.38%
*******
*******
*******
*******
EBITDA
*******
 183.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cronus Pharma Specialities India?

In 2023, Cronus Pharma Specialities India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,970,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 297.00 Cr
Latest Charge Details
Date Lender Amount Status
12 Sep 2025 Others ₹48.00 Cr Open
31 Oct 2018 Others ₹249.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Cronus Pharma Specialities India?

Cronus Pharma Specialities India has a workforce of 272 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cronus Pharma Specialities India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cronus Pharma Specialities India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cronus Pharma Specialities India
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others of Rs. 249.00 Cr registered on 31 Oct 2018 with Charge ID 100218460 was modified on 09 Feb 2026. was documented.

  • Charges

    A charge with Others amounted to Rs. 48.00 Cr with Charge ID 101158378 was registered on 12 Sep 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Cronus Pharma Specialities India Private Limited last Annual general meeting of members was held on 21 Jul 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Cronus Pharma Specialities India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    A charge with Others amounted to Rs. 249.00 Cr with Charge ID 100218460 was registered on 31 Oct 2018. was recorded as a recent event.

  • Director Appointment

    Kavuru Vimal Kumar was appointed as a Director was appointed as a Director on 16 Jul 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cronus Pharma Specialities India Private Limited?

The CIN of Cronus Pharma Specialities India Private Limited is U24232TG2015PTC100543.

Where is Cronus Pharma Specialities India Private Limited headquartered?

Cronus Pharma Specialities India Private Limited is headquartered at Unit 26/B, 19Th Floor , The Headquarters, Orbit, Plot No 30/C, Sy No 83/1, Hyderabad Knowledge City, Raidurg ,Serilingampally Mandal, Shaikpet, Telangana, 500081.

When was Cronus Pharma Specialities India Private Limited incorporated?

Cronus Pharma Specialities India Private Limited was incorporated on 02 September 2015.

Who are the current directors of Cronus Pharma Specialities India Private Limited?

The current directors of Cronus Pharma Specialities India Private Limited are

What is the primary industry of Cronus Pharma Specialities India Private Limited?

The primary industry of Cronus Pharma Specialities India Private Limited is Manufacturing.

Is Cronus Pharma Specialities India Private Limited a listed company?

Cronus Pharma Specialities India Private Limited is unlisted.

What is the capital structure of Cronus Pharma Specialities India Private Limited?

The authorized capital of Cronus Pharma Specialities India Private Limited is ₹190.00 Cr, and the paid-up capital is ₹119.11 Cr.

What is the compliance status of Cronus Pharma Specialities India Private Limited?

The compliance status of Cronus Pharma Specialities India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available